Injectech, LLC

Based in the US, Injectech, LLC provides high-quality biomedical components for medical device applications, focusing on safe fluid management solutions across various healthcare sectors. Injectech, LLC specializes in biomedical components for medical devices, founded in 1998 and headquartered in Fort Collins, US. The company has undergone a recent acquisition by Vance Street Capital in November 2025, merging with Plastic Design Company and Resenex under the VSC Medical Molding Platform. The founder's specific history is not detailed.

Injectech specializes in providing a range of high-quality biomedical components designed specifically for medical device applications. Their core product offerings include Luers, Luer plugs and couplers, tube-to-tube connectors, check valves, and spikes and caps, which are engineered to facilitate safe and effective fluid management in various healthcare scenarios. These products are used across a wide array of medical fields including bioprocessing, cardiology, diagnostics, nuclear medicine, ophthalmology, orthopedics, and respiratory care. By delivering reliable and durable components, Injectech addresses critical challenges in medical device integration and functionality, ensuring compliance with industry standards such as ISO 80369.

The company serves a diverse client base that includes manufacturers of medical devices and healthcare providers primarily in North America, Europe, and parts of Asia. Injectech generates revenue through the sale of its biomedical components directly to manufacturers and healthcare organizations, operating primarily on a B2B model. Transactions are executed through both direct sales and partnerships with distributors, allowing for a broad reach within the medical industry. The pricing structure is tailored to the needs of clients, with considerations for bulk orders and long-term contracts that facilitate consistent supply.

Flagship products such as ISO 80369-compliant connections exemplify the company's commitment to innovation and safety in medical applications, contributing to its reputation as a trusted supplier. Revenue is primarily driven by repeat business from existing clients who require ongoing supplies of specialized components, ensuring a stable financial foundation for the company. In November 2025, Vance Street Capital acquired Injectech from The West Group Limited, with financial terms undisclosed. This acquisition aims to strengthen the VSC Medical Molding Platform's offerings and global presence.

Plans include the design and launch of new products as part of their consolidation with Plastic Design Company and Resenex, with specific release dates to be announced. The strategy also focuses on expanding into new geographic regions, although specific markets have not been detailed.